Urothelial | Maryland Oncology Hematology Urothelial – Maryland Oncology Hematology
Clinical Trial Categories

Urothelial Trials

« Return to Trial Main

Trial ID ESR 22-21698 (EIMPRIS)

NCT05438498
clinicaltrials.gov ID
Phase II/III
Trial Details

Trial ID 20172

NCT03288545
clinicaltrials.gov ID
USOR ID: 20172 Phase I/II
A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer
Trial Details
« Return to Trial Main

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology